Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 10.32
+0.41 (4.14%)
At close: Feb 5, 2026
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 212.73 million as of February 5, 2026. Its market cap has decreased by -16.21% in one year.
Market Cap
212.73M
Enterprise Value
119.17M
Revenue
259.70M
Ranking
n/a
PE Ratio
2.12
Stock Price
10.32
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 212.73M, an increase of 62.32%. That is a compound annual growth rate of 4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 212.73M | 1.22% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Works Technologies AB | 283.36M |
| Xintela AB | 251.49M |
| Elicera Therapeutics AB | 249.96M |
| Magle Chemoswed Holding AB | 235.40M |
| AlzeCure Pharma AB | 228.68M |
| Medivir AB | 202.80M |
| Initiator Pharma | 201.25M |
| NextCell Pharma AB | 182.46M |